106 related articles for article (PubMed ID: 15638326)
1. Biosynthetic investigations of the V-type ATPase inhibitors bafilomycin A1, B1 and concanamycin A.
Schuhmann T; Grond S
J Antibiot (Tokyo); 2004 Oct; 57(10):655-61. PubMed ID: 15638326
[TBL] [Abstract][Full Text] [Related]
2. Archazolid and apicularen: novel specific V-ATPase inhibitors.
Huss M; Sasse F; Kunze B; Jansen R; Steinmetz H; Ingenhorst G; Zeeck A; Wieczorek H
BMC Biochem; 2005 Aug; 6():13. PubMed ID: 16080788
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
[TBL] [Abstract][Full Text] [Related]
4. Biosynthetic origin of the methoxyl extender unit in bafilomycin and concanamycin using stereospecifically labeled precursors.
Schuhmann T; Vollmar D; Grond S
J Antibiot (Tokyo); 2007 Jan; 60(1):52-60. PubMed ID: 17390589
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of V-ATPase inhibition by bafilomycin A1.
Wang R; Wang J; Hassan A; Lee CH; Xie XS; Li X
Nat Commun; 2021 Mar; 12(1):1782. PubMed ID: 33741963
[TBL] [Abstract][Full Text] [Related]
6. Increased production of reactive oxygen species by the vacuolar-type (H(+))-ATPase inhibitors bafilomycin A1 and concanamycin A in RAW 264 cells.
Yokomakura A; Hong J; Ohuchi K; Oh SE; Lee JY; Mano N; Takahashi T; Hwang GW; Naganuma A
J Toxicol Sci; 2012; 37(5):1045-8. PubMed ID: 23038011
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies.
Páli T; Dixon N; Kee TP; Marsh D
Biochim Biophys Acta; 2004 May; 1663(1-2):14-8. PubMed ID: 15157605
[TBL] [Abstract][Full Text] [Related]
8. Semisynthetic derivatives of concanamycin A and C, as inhibitors of V- and P-type ATPases: structure-activity investigations and developments of photoaffinity probes.
Dröse S; Boddien C; Gassel M; Ingenhorst G; Zeeck A; Altendorf K
Biochemistry; 2001 Mar; 40(9):2816-25. PubMed ID: 11258892
[TBL] [Abstract][Full Text] [Related]
9. Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.
Gagliardi S; Rees M; Farina C
Curr Med Chem; 1999 Dec; 6(12):1197-212. PubMed ID: 10519916
[TBL] [Abstract][Full Text] [Related]
10. Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c.
Huss M; Ingenhorst G; König S; Gassel M; Dröse S; Zeeck A; Altendorf K; Wieczorek H
J Biol Chem; 2002 Oct; 277(43):40544-8. PubMed ID: 12186879
[TBL] [Abstract][Full Text] [Related]
11. Mutations in subunit C of the vacuolar ATPase confer resistance to bafilomycin and identify a conserved antibiotic binding site.
Bowman BJ; Bowman EJ
J Biol Chem; 2002 Feb; 277(6):3965-72. PubMed ID: 11724795
[TBL] [Abstract][Full Text] [Related]
12. Organization of the biosynthetic gene cluster for the macrolide concanamycin A in Streptomyces neyagawaensis ATCC 27449.
Haydock SF; Appleyard AN; Mironenko T; Lester J; Scott N; Leadlay PF
Microbiology (Reading); 2005 Oct; 151(Pt 10):3161-3169. PubMed ID: 16207901
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of V-ATPases: old and new players.
Huss M; Wieczorek H
J Exp Biol; 2009 Feb; 212(Pt 3):341-6. PubMed ID: 19151208
[TBL] [Abstract][Full Text] [Related]
14. The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
Osteresch C; Bender T; Grond S; von Zezschwitz P; Kunze B; Jansen R; Huss M; Wieczorek H
J Biol Chem; 2012 Sep; 287(38):31866-76. PubMed ID: 22815478
[TBL] [Abstract][Full Text] [Related]
15. The V-ATPase inhibitors concanamycin A and bafilomycin A lead to Golgi swelling in tobacco BY-2 cells.
Robinson DG; Albrecht S; Moriysu Y
Protoplasma; 2004 Dec; 224(3-4):255-60. PubMed ID: 15614486
[TBL] [Abstract][Full Text] [Related]
16. Archazolid A binds to the equatorial region of the c-ring of the vacuolar H+-ATPase.
Bockelmann S; Menche D; Rudolph S; Bender T; Grond S; von Zezschwitz P; Muench SP; Wieczorek H; Huss M
J Biol Chem; 2010 Dec; 285(49):38304-14. PubMed ID: 20884613
[TBL] [Abstract][Full Text] [Related]
17. Complete elucidation of the late steps of bafilomycin biosynthesis in
Li Z; Du L; Zhang W; Zhang X; Jiang Y; Liu K; Men P; Xu H; Fortman JL; Sherman DH; Yu B; Gao S; Li S
J Biol Chem; 2017 Apr; 292(17):7095-7104. PubMed ID: 28292933
[TBL] [Abstract][Full Text] [Related]
18. Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases.
Bowman EJ; Gustafson KR; Bowman BJ; Boyd MR
J Biol Chem; 2003 Nov; 278(45):44147-52. PubMed ID: 12944415
[TBL] [Abstract][Full Text] [Related]
19. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector.
Páli T; Whyteside G; Dixon N; Kee TP; Ball S; Harrison MA; Findlay JB; Finbow ME; Marsh D
Biochemistry; 2004 Sep; 43(38):12297-305. PubMed ID: 15379568
[TBL] [Abstract][Full Text] [Related]
20. Dissection of autophagy in tobacco BY-2 cells under sucrose starvation conditions using the vacuolar H(+)-ATPase inhibitor concanamycin A and the autophagy-related protein Atg8.
Yano K; Yanagisawa T; Mukae K; Niwa Y; Inoue Y; Moriyasu Y
Plant Signal Behav; 2015; 10(11):e1082699. PubMed ID: 26368310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
